Linqi Ouyang

机构：First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · ORCID：0000-0002-4594-5353

发表论文 16 篇 · 总被引 563 次 · h-index 8

代表论文

Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease (2007 · Kidney International · 被引 371)
Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway (2017 · Biomedicine & Pharmacotherapy · 被引 66)
Imatinib co-loaded targeted realgar nanocrystal for synergistic therapy of chronic myeloid leukemia (2021 · Journal of Controlled Release · 被引 26)
Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy (2022 · Asian Journal of Pharmaceutical Sciences · 被引 24)
DNA adsorption on nanoscale zeolitic imidazolate framework-8 enabling rational design of a DNA-based nanoprobe for gene detection and regulation in living cells (2020 · RSC Advances · 被引 21)
Inhibition of Cell Proliferation and Increase of Chemosensitivity by Simultaneous Knockdown of XIAP and Survivin in Pancreatic Carcinoma Cells (2013 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 被引 13)